NASDAQ : PRAX
Praxis Precision Medicines, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 288.62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 8.06B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.98B |
| Enterprise Value | 6.61B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 27.92M |
| Shares Outstanding | 27.92M |
| Shares Change (YoY) | +29.56% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 109.99% |
| Float | 24.08M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 111.64 |
| PB Ratio | 5.95 |
| P/TBV Ratio | 5.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 15.73 |
| Quick Ratio | 15.46 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -38.86% |
| Return on Assets (ROA) | -25.65% |
| Return on Invested Capital (ROIC) | -27.06% |
| Return on Capital Employed (ROCE) | -28.20% |
| Weighted Average Cost of Capital (WACC) | 19.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.02M |
| Employee Count | 168 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.84 |
| 52-Week Price Change | +46.06% |
| 50-Day Moving Average | 301.29 |
| 200-Day Moving Average | 314.84 |
| Relative Strength Index (RSI) | 55.02 |
| Average Volume (20 Days) | 527,034 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.92M |
| Short Previous Month | 4.19M |
| Short % of Shares Out | 14.05% |
| Short % of Float | 16.29% |
| Short Ratio (days to cover) | 7.11 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | -290.71M |
| Operating Income | -378.17M |
| Pretax Income | -339.13M |
| Net Income | -339.13M |
| EBITDA | -378.05M |
| EBIT | -378.17M |
| Earnings Per Share (EPS) | -$12.86 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 758.55M |
| Total Debt | 1.09M |
| Net Cash | 1.37B |
| Net Cash Per Share | $49.17 |
| Equity (Book Value) | 1.34B |
| Book Value Per Share | 48.04 |
| Working Capital | 722.85M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -305.08M |
| Capital Expenditures | -307,000 |
| Depreciation & Amortization | 119,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -305.38M |
| FCF Per Share | -$10.94 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -29.56% |
| Shareholder Yield | n/a |
| Earnings Yield | -4.50% |
| FCF Yield | -3.83% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $650.00 |
| Price Target Difference | 127.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |